CSC
CDIO icon

Caldwell Sutter Capital’s Cardio Diagnostics CDIO Stock Holding History

Caldwell Sutter Capital’s Portfolio CDIO Stock Details CDIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-270
Closed -$1.81K – 903
2024
Q3 		$1.81K Hold
270
– – ﹤0.01% 768
2024
Q2 		$4.46K Hold
270
– – ﹤0.01% 644
2024
Q1 		$11.5K Hold
270
– – 0.01% 528
2023
Q4 		$20.2K Hold
270
– – 0.01% 466
2023
Q3 		$2.75K Hold
270
– – ﹤0.01% 686
2023
Q2 		$9.64K Hold
270
– – 0.01% 533
2023
Q1 		$31.7K Hold
270
– – 0.02% 296
2022
Q4 		$8.59K Buy
+270
New +$29.2K 0.01% 258

Other funds holding CDIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Caldwell Sutter Capital's CDIO Position: Q4 2024 in Review

Caldwell Sutter Capital sold out of Cardio Diagnostics (CDIO) in Q4 2024, closing a stake of 270 shares — an estimated $1.81K sold.

Caldwell Sutter Capital first reported a position in CDIO in Q4 2022 and held it in 8 quarters. The position peaked at $31.7K in Q1 2023. 23 funds tracked by Wall St. Rank hold CDIO as of Q4 2024.

  • Caldwell Sutter Capital reported no remaining Cardio Diagnostics position as of Q4 2024 after selling out during the quarter.
  • Caldwell Sutter Capital sold 270 Cardio Diagnostics shares in Q4 2024, an estimated $1.81K.
  • Caldwell Sutter Capital first reported a position in Cardio Diagnostics in Q4 2022 and held it in 8 quarters.
  • Caldwell Sutter Capital's Cardio Diagnostics position peaked at $31.7K in Q1 2023.
  • 23 funds tracked by Wall St. Rank held Cardio Diagnostics as of Q4 2024.

Based on Caldwell Sutter Capital's 13F filing for Q4 2024, filed 21 Jan 2025.